Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

RODM

Hartford Multifactor Developed Markets (ex-US) ETF (RODM)

Rating:66Neutral
Price Target:$45.00▲(10.06% Upside)

RODM, the Hartford Multifactor Developed Markets (ex-US) ETF, earns a solid overall rating thanks to several high-quality holdings like Novartis, Roche, GSK, and Fairfax Financial, which all show strong financial performance, healthy cash flows, and generally positive technical momentum and earnings call sentiment. Some positions, such as Ericsson and TotalEnergies, add value through attractive valuations and supportive technical trends but face risks from weaker revenue growth, profitability challenges, and external factors like tax environments. The main risk for the ETF is its meaningful exposure to stocks that are showing overbought technical conditions or valuation concerns, which could limit near-term upside.

Positive Factors
Strong Recent PerformanceThe fund has shown strong year-to-date and steady short-term performance, suggesting its strategy has worked well in the current market.
Broad International DiversificationThe ETF spreads its investments across many developed countries outside the U.S., which helps reduce the impact of problems in any single market.
Solid Top Holdings in Health Care and EnergySeveral of the largest positions, especially in health care and energy, have delivered strong gains, supporting the fund’s overall returns.
Negative Factors
Moderate Expense RatioThe fund’s fees are not extremely high but are also not among the very lowest, which slightly reduces the net return investors keep.
Country Concentration in Japan and North AmericaA significant portion of the portfolio is concentrated in Japan and North American markets, which can increase risk if those regions face downturns.
Limited Technology ExposureThe ETF has relatively low exposure to the technology sector, which could cause it to lag if tech stocks continue to be strong drivers of global market gains.

RODM vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%SPY+13.11%RODM+17.93%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
1.67B
Region
Developed Markets
Expense Ratio
0.29%
Beta
0.46
Issuer
Hartford
Inception Date
Feb 25, 2015
Dividend Yield
2.83%
Asset Class
Equity
Index Tracked
Hartford Risk-Optimized Multi Developed Markets Ex-US Index

RODM Summary

RODM is an exchange-traded fund that follows the Hartford Risk-Optimized Multi Developed Markets Ex-US Index, giving you broad exposure to stocks from developed countries outside the United States, such as Japan, the UK, and Canada. It owns a wide mix of companies across many industries, including well-known names like Roche and Novartis, which helps spread your risk and offers international diversification in one investment. This ETF may appeal to investors who want long-term growth and a more globally balanced portfolio. A key risk is that international stock prices can go up and down with global markets and currency changes.

How much will it cost me?

This ETF has an expense ratio of 0.29%, which means you’ll pay about $2.90 per year for every $1,000 you invest. That’s a bit higher than the average low-cost index ETF because it uses an actively designed multifactor strategy rather than simple passive tracking.

What would affect this ETF?

RODM could benefit from steady growth in developed markets outside the U.S., especially if global economic conditions improve and sectors like financials, industrials, and health care continue to perform well, supporting its diversified mix of companies such as Roche, Novartis, and Shell. On the downside, rising interest rates, slower growth in Europe or Japan, currency swings, or new regulations affecting energy and large international firms could weigh on returns and add volatility to this broad international ETF.

RODM Top 10 Holdings

RODM leans heavily on big international health care and energy names, with Roche, Novartis, and Astellas Pharma all rising and giving the fund a steady defensive backbone. On the energy side, TotalEnergies and Shell have been strong performers, acting like twin engines pushing returns higher as global energy markets stay firm. Ericsson adds a bit of tech flavor with solid recent momentum, while Canon and GSK are more mixed, occasionally dragging on the fund’s pace. Overall, it’s a diversified, developed-markets ex-US play with a clear tilt toward European and Japanese blue chips.

RODM top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
SE:ERIC.BSE:ERIC.BTelefonaktiebolaget LM Ericsson Class B1.02%$16.93MSEK 349.38B15.98%72Outperform
RHHVFRHHVFRoche Holding AG――――73Outperform
ALPMFALPMFAstellas Pharma――――69Neutral
FR:TTEFR:TTETotalEnergies SE1.00%$16.65MEUR 178.15B43.88%78Outperform
CH:NOVNCH:NOVNNovartis AG0.99%$16.43MCHF 243.98B28.90%80Outperform
GSKGSKGlaxoSmithKline0.92%$15.23M$97.86B2.55%77Outperform
FRFHFFRFHFFairfax Financial Holdings――――81Outperform
NL:ADNL:ADKoninklijke Ahold Delhaize N.V.0.88%$14.65MEUR 30.15B-1.97%62Neutral

RODM Technical Analysis

Technical Analysis SentimentNegative
Last Price40.88

Price Trends

50DMA41.62Negative
100DMA41.60Negative
200DMA40.72Positive

Market Momentum

MACD-0.02Positive
RSI38.81Neutral
STOCH26.60Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RODM, the sentiment is Negative. The current price of 40.88 is below the 20-day moving average (MA) of 41.97, below the 50-day MA of 41.62, and above the 200-day MA of 40.72, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 38.81 is Neutral, neither overbought nor oversold. The STOCH value of 26.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RODM.

RODM Peer Comparison

Comparison Results

RODM against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
RODMRODM$40.89$45.00(10.06% Upside)$1.67B0.29%66Neutral
LVHILVHI$42.66$46.97(10.10% Upside)$6.67B0.40%69Neutral
GSIEGSIE$44.85$52.90(17.95% Upside)$5.92B0.25%65Neutral
IDMOIDMO$53.96$69.01(27.89% Upside)$4.00B0.25%71Outperform
IMTMIMTM$47.66$61.46(28.95% Upside)$3.97B0.30%69Neutral
INTFINTF$39.84$47.58(19.43% Upside)$3.67B0.16%64Neutral

Performance Comparison

0%10%20%RODMLVHIGSIEIDMOIMTMINTFDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
RODM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
RODMHartford Multifactor Developed Markets (ex-US) ETF40.886.7819.88%
LVHILegg Mason International Low Volatility High Dividend ETF42.668.4324.62%
GSIEGoldman Sachs ActiveBeta International Equity ETF44.855.8715.05%
IDMOInvesco S&P International Developed Momentum ETF53.963.677.30%
IMTMiShares MSCI Intl Momentum Factor ETF47.663.437.76%
INTFiShares MSCI Intl Multifactor ETF39.845.4915.98%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.